Patents Examined by Narayan K Bhat
  • Patent number: 11199540
    Abstract: Some examples described herein relate to a substrate comprising a silane functionalized surface for reversibly immobilizing a biological molecule of interest, such as oligonucleotides, polynucleotides, or protein. Methods for immobilizing the biological molecule and the use in DNA sequencing and other diagnostic applications are also disclosed.
    Type: Grant
    Filed: June 3, 2020
    Date of Patent: December 14, 2021
    Assignee: Illumina Cambridge Limited
    Inventors: Xavier von Hatten, Wayne N. George, Alexandre Richez, Anne-Cecile Dingwall, Andrew A. Brown
  • Patent number: 11192105
    Abstract: An analysis system may perform operations on an analyte that may be combined with multiple regents prior to being introduced into a flow cell. The instrument may include a volume into which the reagents to be combined with the analyte are aspirated one-by-one. The volume may be formed as a serpentine channel in a valve manifold associated with sippers for aspirating the reagents. The reagents may then be mixed by cycling a pump to move the reagents within the mixing volume or channel. For this, the reagents may be aspirated from a recipient into the volume or channel, ejected back into the recipient, and this process may be performed repeatedly to enhance mixing.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: December 7, 2021
    Assignee: Illumina, Inc.
    Inventors: Bradley Kent Drews, Michael Dai Wang, Umberto Ulmanella, Stephen Wayne Clark, Johanna Lynn Whitacre, Steven Scott Phelps, Michelle L. Alvarez, Michael Adalbert Niziolek, Debra Sue Bryan, Joshua Augustin Darland
  • Patent number: 11186869
    Abstract: A sequencing device has at least one sequencing channel configured to fluidically connect a first gap with a second gap. The sequencing channel is formed as a cavity in the region of the first gap and is formed as a pore in the region of the second gap. The pore has a smaller cross section than the cavity.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: November 30, 2021
    Assignee: Robert Bosch GmbH
    Inventors: Jochen Hoffmann, Karin Lemuth
  • Patent number: 11174512
    Abstract: Nucleic acid memory strands encoding digital data using a sequence of homopolymer tracts of repeated nucleotides provides a cheaper and faster alternative to conventional digital DNA storage techniques. The use of homopolymer tracts allows for lower fidelity, high throughput sequencing techniques such as nanopore sequencing to read data encoded in the memory strands. Specialized synthesis techniques allow for synthesis of long memory strands capable of encoding large volumes of data despite the reduced data density afforded by homopolymer tracts as compared to conventional single nucleotide sequences.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: November 16, 2021
    Assignee: Molecular Assemblies, Inc.
    Inventors: J. William Efcavitch, Matthew T. Holden
  • Patent number: 11168363
    Abstract: The invention relates to a new method of sequencing a double stranded target polynucleotide. The two strands of the double stranded target polynucleotide are linked by a bridging moiety. The two strands of the target polynucleotide are separated using a polynucleotide binding protein and the target polynucleotide is sequenced using a transmembrane pore.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: November 9, 2021
    Assignee: Oxford Nanopore Technologies Ltd.
    Inventors: Clive Gavin Brown, James Anthony Clarke, Graham Hall, Gavin Harper, Andrew John Heron, James White
  • Patent number: 11168361
    Abstract: A chip, a detection system and a gene sequencing method are provided. When the chip is used for gene sequencing, sample genes and reversible terminating nucleotides are added into micropores and matched therein to release hydrogen ions such that a Nernst potential is induced on an ion-sensitive film surface, and a voltage is applied to the transparent electrode layer to generate an electric field, thereby controlling the switching layer to change its state, and then a base type of the genes is determined based on a type of reversible terminating nucleotide corresponding to information of light emitted from the switching layer upon changes in the state of the switching layer, thereby gene sequencing is achieved.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: November 9, 2021
    Assignees: BOE TECHNOLOGY GROUP CO., LTD., BEIJING BOE OPTOELECTRONICS TECHNOLOGY CO., LTD.
    Inventors: Fengchun Pang, Peizhi Cai, Yue Geng
  • Patent number: 11168365
    Abstract: Disclosed herein are compositions, probes, devices, and processes useful for detecting specific reactions and binding interactions with biological molecules. In certain embodiments, methods of binding one or more biomolecules to a solid support are disclosed. Methods of generating site-specific sequences for one or more biomolecules from a solid support are also disclosed. Biological complexes generated by these methods are also disclosed.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: November 9, 2021
    Assignee: VIBRANT HOLDINGS, LLC
    Inventor: John J. Rajasekaran
  • Patent number: 11162147
    Abstract: The present disclosure provides a low cost, high sensitivity, high specificity and rapid diagnostic apparatus and method to detect nucleic acids in a sample at room temperature. As low as tens of copies of nucleic acids can be detected without any additional equipment.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: November 2, 2021
    Assignee: Arizona Board of Regents on Behalf of Arizona State University
    Inventor: Shengxi Chen
  • Patent number: 11162091
    Abstract: Disclosed herein are lysis reagents for lysing red blood cells, thereby releasing an analyte, such as RNA from a host or pathogen, in a form suitable for analysis. The reagent includes at least a buffer, a detergent and one or both of a chloride containing salt and an anti-coagulant. The reagent serves to lyse blood cells, protect the released analyte from degradation in the lysate, and is compatible with subsequent steps for analysis of the analyte such as target capture, amplification, detection, or sequencing.
    Type: Grant
    Filed: April 26, 2017
    Date of Patent: November 2, 2021
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Kui Gao, Jijumon Chelliserry, Jeffrey Linnen
  • Patent number: 11156603
    Abstract: Provided herein are methods of identifying a target protein in a tissue sample that include delivering a plurality of probes to a tissue sample, where a probe of the plurality of probes comprises an antibody conjugated to an oligonucleotide having a sequence, where the antibody specifically binds to the target protein in the tissue sample; amplifying the oligonucleotide to generate an amplicon comprising copies of the oligonucleotide; detecting all or a portion of a copy of the oligonucleotide in the amplicon; and using the detected sequence to identify the target protein in the tissue sample.
    Type: Grant
    Filed: May 14, 2021
    Date of Patent: October 26, 2021
    Assignee: Prognosys Biosciences, Inc.
    Inventor: Mark S. Chee
  • Patent number: 11143618
    Abstract: Embodiments of the present technology may allow for improved and more reliable tunneling junctions and methods of fabricating the tunneling junctions. Electrical shorting issues may be reduced by depositing electrodes without a sharp sidewall and corner but instead with a sloping or curved sidewall. Layers deposited on top of the electrode layer may then be able to adequately cover the underlying electrode layer and therefore reduce or prevent shorting. Additionally, two insulating materials may be used as the dielectric layer may reduce the possibility of incomplete coverage and the possibility of flaking. Furthermore, the electrodes may be tapered from the contact area to the junction area to provide a thin electrode where the hole is to be patterned, while the thicker contact area reduces sheet resistance. The electrode may also be patterned to be wider at the contact area and narrower at the junction area.
    Type: Grant
    Filed: April 5, 2019
    Date of Patent: October 12, 2021
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Juraj Topolancik, Zsolt Majzik, Flint Mitchell
  • Patent number: 11136624
    Abstract: A DNA sequencing device, and related methods, include a nanochannel sized to receive a DNA strand, a first electrode member exposed within the nanochannel, and a second electrode member exposed within the nanochannel and spaced apart from the first electrode to form an electrode gap. The second electrode member has a wedge shaped profile, and the first and second electrode members are operable to detect a change in electronic signal as the DNA strand passes through the electrode gap.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: October 5, 2021
    Assignee: SEAGATE TECHNOLOGY LLC
    Inventors: Kim Yang Lee, David S. Kuo, Thomas Young Chang, Xiaomin Yang, ShuaiGang Xiao, Koichi Wago
  • Patent number: 11124823
    Abstract: Provided herein are methods, compositions, systems, devices, and kits for quantification of RNA, and determination of efficiency of reverse transcription of RNA to cDNA.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: September 21, 2021
    Assignee: Becton, Dickinson and Company
    Inventors: Glenn Fu, Julie Wilhelmy
  • Patent number: 11123733
    Abstract: Described are microfluidic devices and methods for providing a predetermined number of microspheres or beads, together with a cell, within a fluid droplet being processed. The system may provide each droplet with a single bead and a single cell, and the bead may contain DNA or other reagents for later identifying the specific cell associated with that bead.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: September 21, 2021
    Assignee: Illumina, Inc.
    Inventors: Hamed Amini, Arash Jamshidi, Tarun Kumar Khurana, Foad Mashayekhi, Yir-Shyuan Wu
  • Patent number: 11111533
    Abstract: A method of sequencing a plurality of polynucleotides includes: attaching a single DNA template molecule to each of a plurality of attachment elements on a sample container, wherein the average distance between adjacent elements is less than Abbe's limit; applying a stochastic photo-switching chemistry to all of the molecules at the same time to cause the attached molecules to fluoresce in on and off events in up to four different colors by stochastic photo-switching; and imaging the on and off events in a color channel for each color in real-time as the on and off events are occurring for the attached molecules.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: September 7, 2021
    Assignees: ILLUMINA CAMBRIDGE LIMITED, ILLUMINA, INC.
    Inventors: Gary Mark Skinner, Geraint Wyn Evans, Stanley S. Hong
  • Patent number: 11097275
    Abstract: A microfluidic device for performing physical, chemical or biological treatment to at least one packet without contamination.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: August 24, 2021
    Assignees: INSTITUT CURIE, CENTRE NATIONALE DE RECHERCHE SCIENTIFIQUE
    Inventors: Jean-Louis Viovy, Max Chabert, Kevin Dorfman
  • Patent number: 11085036
    Abstract: Systems, methods, and compositions provided herein relate to preparation of beads encapsulating biomolecules for performing sequential reactions on the biomolecules. Some embodiments include preparation of nucleic acid reactions within the bead, wherein the bead includes pores that allow diffusion of molecules into or out of the beads while retaining other molecules of interest.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: August 10, 2021
    Assignee: Illumina, Inc.
    Inventors: Steven Norberg, Dmitry Pokholok, Ramesh Ramji, Frank J. Steemers, Fan Zhang
  • Patent number: 11085064
    Abstract: A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed. The system is designed to dynamically adjust motor idle torque to control heat load and employs a fast focus process for determining the true focus position of an individual microorganism. The system also may quantify the relative abundance of viable microorganisms in a sample using dynamic dilution, and facilitate growth of microorganisms in customized media for rapid, accurate antimicrobial susceptibility testing.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: August 10, 2021
    Assignee: Accelerate Diagnostics, Inc.
    Inventors: Austin Ashby, Wayne Showalter, Jasmin Cote
  • Patent number: 11078522
    Abstract: This disclosure provides microwell capsule array devices. The microwell capsule array devices are generally capable of performing one or more sample preparation operations. Such sample preparation operations may be used as a prelude to one more or more analysis operations. For example, a device of this disclosure can achieve physical partitioning and discrete mixing of samples with unique molecular identifiers within a single unit in preparation for various analysis operations. The device may be useful in a variety of applications and most notably nucleic-acid-based sequencing, detection and quantification of gene expression and single-cell analysis.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: August 3, 2021
    Assignee: 10X GENOMICS, INC.
    Inventors: Benjamin Hindson, Serge Saxonov, Michael Schnall-Levin
  • Patent number: 11078477
    Abstract: The present teachings relate to methods, kits and devices for performing automated sequential nucleic acid isolation and conversion/purification in a single closed system. In various embodiments, the present teaching enable a user to (i) load a device with test samples, reagents and consumables; (ii) select or program the device for the desired nucleic acid isolation and subsequent chemical treatment and/or conversion reaction(s) without further user intervention; and recovering the isolated and treated and/or converted nucleic acid at the conclusion of the program once the device is activated.
    Type: Grant
    Filed: October 24, 2019
    Date of Patent: August 3, 2021
    Assignee: BIOCHAIN INSTITUTE, INC.
    Inventors: Xiaoliang Han, James Jianming Wang, Tong Lu